Keyphrases
Sectional Analysis
100%
Randomized Controlled Trial
72%
Clinical Trials
70%
Meta-analysis
67%
Systematic Meta-analysis
64%
United States
38%
Clinical Practice Guidelines
34%
Amphibians
28%
Behavioral Risk Factor Surveillance System (BRFSS)
27%
Core Outcome Set
27%
Embase
27%
Scoping Review
26%
Conflict of Interest
26%
MEDLINE
25%
Clinical Trial Registry
25%
PubMed
24%
Patient-reported Outcomes
24%
Patient Outcomes
23%
Opioids
23%
Reporting Guidelines
22%
Data Extraction
22%
Risk-benefit
21%
Reporting Quality
20%
Patient Benefit
20%
Drug Development
20%
Patient Risk
19%
Risk Outcomes
19%
Health Inequities
19%
Inclusion Criteria
18%
Person-centered Language
17%
Harms Reporting
17%
Adverse childhood Experiences
17%
Oklahoma
17%
Dinosaurs
16%
Vertebrates
16%
Inequity
15%
Candida Albicans (C. albicans)
14%
AMSTAR
14%
Morphine
14%
Methodological Quality
13%
Opioid Receptors
13%
Consolidated Standards of Reporting Trials (CONSORT)
13%
Meta-epidemiological Study
12%
Risk of Bias
12%
Financial Conflicts of Interest
12%
Frog
11%
COVID-19 Pandemic
11%
Gender Representation
11%
Predatory Journals
11%
National Institutes of Health
11%
Area Postrema
11%
Analgesia
11%
Public Interest
11%
Funding Sources
11%
Journal Publishing
11%
Race-ethnicity
11%
Naloxone
10%
Arginine Vasopressin
10%
Google Forms
10%
Ovid
10%
Reporting Item
10%
Chlamydomonas
10%
Non-publication
10%
Osteopathy
10%
Alcohol Use Disorder
9%
Antinociception
9%
Sodium Chloride
9%
Patient Care
9%
Trialists
9%
μ-opioid Receptor
9%
Obesity
9%
Comorbidity
9%
Opioid Antagonist
9%
Childrens
8%
C.albicans
8%
National Survey
8%
Frequently Asked Questions
8%
North America
8%
Midwest
8%
Search Interest
8%
Dexmedetomidine
8%
Estrogen
8%
Urology
8%
Rana pipiens
8%
Older Adults
8%
Native American
8%
Public Awareness
8%
Measuring Instrument
8%
Antinociceptive
8%
Medical Literature
7%
Sex Differences
7%
Adverse Events
7%
Adjusted Odds Ratio
7%
Cochrane
7%
Blood Pressure
7%
Institutional Review Board
7%
Opioid Analgesics
7%
Review Authors
7%
Cerebellum
7%
Web-based Survey
7%